Hospira (HSP)

Add to Watchlists Create an Alert
35.18 -0.22  -0.62%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Hospira Return on Equity:

-2.41% for March 31, 2013
View Full Chart

Hospira Return on Equity Chart

    Hospira Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -2.41%
    Dec. 31, 2012 1.47%
    Sept. 30, 2012 -5.77%
    June 30, 2012 -8.49%
    March 31, 2012 -3.70%
    Dec. 31, 2011 -0.29%
    Sept. 30, 2011 8.07%
    June 30, 2011 13.19%
    March 31, 2011 11.78%
    Dec. 31, 2010 12.17%
    Sept. 30, 2010 14.10%
    June 30, 2010 16.85%
    March 31, 2010 15.76%
    Dec. 31, 2009 18.39%
    Sept. 30, 2009 20.08%
    June 30, 2009 19.17%
    March 31, 2009 22.05%
       
    Dec. 31, 2008 17.16%
    Sept. 30, 2008 15.90%
    June 30, 2008 15.40%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    HSP Return on Equity Benchmarks

    Companies
    Durect Corporation -59.09%
    Cumberland Pharmaceuticals 7.48%
    Cubist Pharmaceuticals 13.56%

    HSP Return on Equity Rankings

    Overall 57th percentile
    3372 of 8009
    Sector 64th percentile
    241 of 687 in Healthcare
    Industry 60th percentile
    27 of 69 in Drug Manufacturers - Specialty & Generic

    HSP Return on Equity Range, Past 5 Years

    Minimum -8.49% Jun 2012
    Maximum 22.05% Mar 2009
    Average 10.04%